Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test

The aim of this work is to present the two one-sided test (TOST) as an alternative approach to compare dissolution profiles of extended-release dosage forms. The dissolution profiles of oxycodone extended-release tablets containing 10 mg, 20 mg and 40 mg (reference and generic) were evaluated accord...

Full description

Bibliographic Details
Main Authors: Felipe Rebello Lourenço, Daniela Dal Molim Ghisleni, Rosa Noriko Yamamoto, Terezinha de Jesus Andreoli Pinto
Format: Article
Language:English
Published: Universidade de São Paulo 2013-06-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000200019&lng=en&tlng=en
id doaj-bd49a0739f1c4ffc8d23e9dd6a87dc86
record_format Article
spelling doaj-bd49a0739f1c4ffc8d23e9dd6a87dc862020-11-24T23:30:17ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902013-06-0149236737110.1590/S1984-82502013000200019S1984-82502013000200019Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence testFelipe Rebello Lourenço0Daniela Dal Molim Ghisleni1Rosa Noriko Yamamoto2Terezinha de Jesus Andreoli Pinto3Universidade de São PauloUniversidade de São PauloUniversidade de São PauloUniversidade de São PauloThe aim of this work is to present the two one-sided test (TOST) as an alternative approach to compare dissolution profiles of extended-release dosage forms. The dissolution profiles of oxycodone extended-release tablets containing 10 mg, 20 mg and 40 mg (reference and generic) were evaluated according to the requirements described in United States Pharmacopeia. These dissolution profiles were compared using the conventional similarity factor (f2) and the proposed TOST as an equivalence test. TOST is a simple and alternative approach to compare dissolution profiles of extended-release dosage forms. It allows us to identify the time-point (or time-points) that did not show similarity. We concluded that the two one-sided test performed at a significance level of 5% and defined as D = 10 showed results comparable to those obtained by the conventional similarity factor (f2).http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000200019&lng=en&tlng=enPerfil de dissoluçãoComprimidos de liberação prolongadaFator de semelhançaTest uni-caudal duploTeste de equivalência
collection DOAJ
language English
format Article
sources DOAJ
author Felipe Rebello Lourenço
Daniela Dal Molim Ghisleni
Rosa Noriko Yamamoto
Terezinha de Jesus Andreoli Pinto
spellingShingle Felipe Rebello Lourenço
Daniela Dal Molim Ghisleni
Rosa Noriko Yamamoto
Terezinha de Jesus Andreoli Pinto
Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
Brazilian Journal of Pharmaceutical Sciences
Perfil de dissolução
Comprimidos de liberação prolongada
Fator de semelhança
Test uni-caudal duplo
Teste de equivalência
author_facet Felipe Rebello Lourenço
Daniela Dal Molim Ghisleni
Rosa Noriko Yamamoto
Terezinha de Jesus Andreoli Pinto
author_sort Felipe Rebello Lourenço
title Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
title_short Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
title_full Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
title_fullStr Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
title_full_unstemmed Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
title_sort comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
publisher Universidade de São Paulo
series Brazilian Journal of Pharmaceutical Sciences
issn 2175-9790
publishDate 2013-06-01
description The aim of this work is to present the two one-sided test (TOST) as an alternative approach to compare dissolution profiles of extended-release dosage forms. The dissolution profiles of oxycodone extended-release tablets containing 10 mg, 20 mg and 40 mg (reference and generic) were evaluated according to the requirements described in United States Pharmacopeia. These dissolution profiles were compared using the conventional similarity factor (f2) and the proposed TOST as an equivalence test. TOST is a simple and alternative approach to compare dissolution profiles of extended-release dosage forms. It allows us to identify the time-point (or time-points) that did not show similarity. We concluded that the two one-sided test performed at a significance level of 5% and defined as D = 10 showed results comparable to those obtained by the conventional similarity factor (f2).
topic Perfil de dissolução
Comprimidos de liberação prolongada
Fator de semelhança
Test uni-caudal duplo
Teste de equivalência
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000200019&lng=en&tlng=en
work_keys_str_mv AT feliperebellolourenco comparisonofdissolutionprofileofextendedreleaseoraldosageformstwoonesidedequivalencetest
AT danieladalmolimghisleni comparisonofdissolutionprofileofextendedreleaseoraldosageformstwoonesidedequivalencetest
AT rosanorikoyamamoto comparisonofdissolutionprofileofextendedreleaseoraldosageformstwoonesidedequivalencetest
AT terezinhadejesusandreolipinto comparisonofdissolutionprofileofextendedreleaseoraldosageformstwoonesidedequivalencetest
_version_ 1725541946286407680